Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: System Suitability Limits Design for HPLC – V 2.0

Posted on By

Analytical Method Development: System Suitability Limits Design for HPLC – V 2.0

SOP for Designing System Suitability Limits in HPLC Method Development


Department Analytical Method Development
SOP No. SOP/AMD/082/2025
Supersedes SOP/AMD/082/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP provides a structured approach for designing and evaluating system suitability parameters during HPLC method development. Establishing robust system suitability ensures chromatographic system integrity and reliable analytical results.

2. Scope

This procedure applies to all HPLC-based analytical methods developed and validated in the Analytical Method Development (AMD) laboratory for pharmaceutical raw materials, intermediates, and finished drug products.

3. Responsibilities

  • Analytical Chemist: Designs, executes, and evaluates system suitability tests and documents results.
  • Reviewer: Verifies compliance of system suitability parameters with acceptance criteria.
  • QA Officer: Ensures documentation aligns with regulatory standards.
  • Head – AMD: Approves system suitability limits before method validation or transfer.

See also  Analytical Method Development: Integration with Product Development Team - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring system suitability limits are scientifically justified and documented for each HPLC method developed.

5. Procedure

5.1 Identification of System Suitability Parameters

  1. Determine applicable parameters based on method type:
    • Assay/related substances: Resolution, %RSD, tailing factor
    • Impurity profiling: LOD/LOQ, S/N ratio
    • Dissolution or uniformity: Retention time consistency
  2. Document in Annexure-1: Suitability Parameter Planning Sheet.

5.2 Experimental Determination of Limits

  1. Inject standard solution (n=5–6 replicates) at target concentration.
  2. Measure the following:
    • Retention time (RT)
    • Peak area and %RSD
    • Resolution (Rs) between critical peaks
    • Tailing factor
    • Theoretical plates (efficiency)
  3. Calculate mean, %RSD, and define acceptance limits based on observed variability.
  4. Example: If mean tailing factor = 1.10 with %RSD = 0.4%, acceptable limit = ≤1.5.
  5. Record in Annexure-2: Experimental Results Log.

5.3 Criteria for Limit Setting

  1. Follow regulatory guidelines and best practices:
    • %RSD for replicate injections: ≤ 2.0% for assay; ≤ 5.0% for impurities
    • Tailing Factor: ≤ 2.0
    • Resolution: ≥ 2.0 between critical pairs
    • Plate Count: ≥ 2000 for assay; ≥ 1000 for impurities
  2. If observed results are tighter, set stricter in-house limits (e.g., %RSD ≤ 1.5%).
  3. Document final selected limits in Annexure-3: Final Suitability Limits Sheet.
See also  Analytical Method Development: SOP for Dissolution Media Filtering and Degassing - V 2.0

5.4 System Suitability Protocol Execution

  1. Prepare fresh standard solution at working concentration.
  2. Inject standard (minimum 5 replicates).
  3. Evaluate against defined limits.
  4. Document compliance in Annexure-4: Routine System Suitability Report.

5.5 Investigation and Troubleshooting

  1. If limits are not met, perform checks:
    • Re-prepare mobile phase and standards
    • Replace column or injector components
    • Clean system lines and autosampler
  2. Document corrective actions in Annexure-5: System Suitability Deviation Log.

5.6 Integration with Method Validation

  1. System suitability limits must be included in method validation protocols and reports.
  2. Limits should be verified during each validation parameter (precision, linearity, robustness).
  3. Include as a section in final Method Development Report and SOP.

6. Abbreviations

  • HPLC: High-Performance Liquid Chromatography
  • RT: Retention Time
  • Rs: Resolution
  • RSD: Relative Standard Deviation
  • SOP: Standard Operating Procedure

7. Documents

  1. Suitability Parameter Planning Sheet – Annexure-1
  2. Experimental Results Log – Annexure-2
  3. Final Suitability Limits Sheet – Annexure-3
  4. Routine System Suitability Report – Annexure-4
  5. System Suitability Deviation Log – Annexure-5
See also  Analytical Method Development: Morphology Assessment SOP - V 2.0

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <621> – Chromatography
  • FDA Guidance for Industry – Analytical Procedures and Methods Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Suitability Parameter Planning Sheet

Parameter Justification Applicable To
Resolution Impurity separation Impurity method
%RSD Precision check Assay/Content Uniformity

Annexure-2: Experimental Results Log

Injection No. RT Area Tailing Plate Count
1 4.25 106574 1.11 3200

Annexure-3: Final Suitability Limits Sheet

Parameter Limit Rationale
%RSD ≤ 1.5% Observed RSD from replicates
Resolution ≥ 2.0 Regulatory compliance

Annexure-4: Routine System Suitability Report

Parameter Value Status
%RSD (n=5) 1.22% Complies

Annexure-5: System Suitability Deviation Log

Date Issue Action Taken Verified By
17/05/2025 High tailing factor Column replaced Sunita Reddy

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Included deviation log and rationale annexure Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: API Manufacturing: SOP for Analytical Method Transfer to QC – V 2.0
Next Post: BA-BE Studies: SOP for Sample Thawing and Equilibration – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version